We are live on
!
Find out more
VanEck Associates Portfolio holdings
AUM
$133B
1-Year Est. Return
72.99%
This Fund
S&P 500
This Quarter
Est. Return
-6.94%
1 Year Est. Return
+72.99%
3 Year Est. Return
+157.94%
5 Year Est. Return
+206.35%
10 Year Est. Return
+770.56%
AUM
$33.6B
AUM Growth
-$4.11B
(-11%)
Cap. Flow
-$868M
Cap. Flow
% of AUM
-2.58%
Top 10 Holdings %
Top 10 Hldgs %
23.36%
Holding
1,444
New
70
Increased
662
Reduced
591
Closed
59
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$174M |
| 2 |
Applied Materials
AMAT
|
+$106M |
| 3 |
Fortinet
FTNT
|
+$93.1M |
| 4 |
Comcast
CMCSA
|
+$92.9M |
| 5 |
Valaris
VAL
|
+$91.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
K
Kellanova
K
|
+$115M |
| 2 |
SLB Ltd
SLB
|
+$106M |
| 3 |
Campbell Soup
CPB
|
+$105M |
| 4 |
Merck
MRK
|
+$105M |
| 5 |
Constellation Brands
STZ
|
+$100M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Materials | 33.63% |
| 2 | Technology | 27% |
| 3 | Energy | 8.42% |
| 4 | Healthcare | 7.19% |
| 5 | Financials | 5.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
176
RPC Inc
RES
$1.2B
| $33.5M | 0.1% |
4,839,644
-2,657,292
| -35% | -$19.3M |
|
177
Ormat Technologies
ORA
$5.94B
| $30.8M | 0.09% |
357,148
-16,997
| -5% | -$1.51M |
|
178
Cisco
CSCO
$448B
| $30.6M | 0.09% |
764,819
+69,952
| +10% | +$3.1M |
|
179
Sigma Lithium
SGML
$1.12B
| $30.6M | 0.09% |
1,124,805
+1,107,401
| +6,363% | +$23.2M |
|
180
Unity
U
$14.6B
| $30.4M | 0.09% |
955,327
+8,534
| +0.9% | +$351K |
|
|
NEE.PRQ
181
DELISTED
NextEra Energy, Inc. 6.219% Corporate Units
NEE.PRQ
| $30.3M | 0.09% |
624,625
+91,035
| +17% | +$4.76M |
|
182
Hannon Armstrong Sustainable Infrastructure Capital
HASI
$4.85B
| $30.2M | 0.09% |
1,009,099
-647,809
| -39% | -$24.2M |
|
183
Sibanye-Stillwater
SBSW
$6.43B
| $29.5M | 0.09% |
3,165,812
-159,130
| -5% | -$1.51M |
|
184
Invesco Actively Managed Exch-Traded Commodity Fd Tr Invesco Optimum Yield Diversified Commodity Strategy No K-1 ETF
PDBC
$6.36B
| $29.4M | 0.09% |
1,817,852
-249,717
| -12% | -$4.28M |
|
185
McKesson
MCK
$101B
| $29M | 0.09% |
85,409
-17,853
| -17% | -$6.2M |
|
|
PCGU
186
DELISTED
PG&E Corporation
PCGU
| $28.5M | 0.08% |
249,850
+36,406
| +17% | +$3.98M |
|
187
Toro Company
TTC
$8.72B
| $28.4M | 0.08% |
328,186
-29,314
| -8% | -$2.51M |
|
|
ORLA
188
Orla Mining
ORLA
$3.54B
| $28.3M | 0.08% |
8,668,315
+1,213,737
| +16% | +$3.72M |
|
189
Kirby Corp
KEX
$7.08B
| $27.6M | 0.08% |
454,110
-22,830
| -5% | -$1.46M |
|
190
Prologis
PLD
$136B
| $27M | 0.08% |
265,661
-107,902
| -29% | -$13.4M |
|
191
Universal Display
OLED
$3.76B
| $26.3M | 0.08% |
278,339
-14,963
| -5% | -$1.66M |
|
|
NVO
192
Novo Nordisk
NVO
$228B
| $26.2M | 0.08% |
525,378
+8,318
| +2% | +$446K |
|
193
Novartis
NVS
$301B
| $25.9M | 0.08% |
340,215
-2,989
| -0.9% | -$248K |
|
194
Haleon
HLN
$44.5B
| $25.8M | 0.08% |
+4,236,499
| New | +$27.4M |
|
195
AstraZeneca
AZN
$266B
| $25.2M | 0.08% |
230,168
-1,439
| -0.6% | -$183K |
|
196
Cencora
COR
$60.7B
| $25.1M | 0.07% |
185,827
-15,346
| -8% | -$2.2M |
|
197
Moderna
MRNA
$23B
| $24.8M | 0.07% |
209,480
+13,342
| +7% | +$2.02M |
|
198
Accenture
ACN
$99.9B
| $24.6M | 0.07% |
95,746
+4,388
| +5% | +$1.27M |
|
|
SLCA
199
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
| $24.5M | 0.07% |
2,238,048
-1,512,337
| -40% | -$19.2M |
|
200
Takeda Pharmaceutical
TAK
$55.1B
| $24.1M | 0.07% |
1,862,022
-127,750
| -6% | -$1.78M |
|
Similar funds
VanEck Associates's Q3 2022 Portfolio in Review
As of Q3 2022, VanEck Associates held 1,444 positions worth $33.6B, down 11% from $37.7B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
VanEck Associates's Q3 2022 filing shows 70 new, 662 increased, 591 reduced and 59 closed positions. Its largest new stake was Valaris: 1,902,492 shares worth $93.1M. The largest sale was Kellanova, an estimated $115M.
By sector, the portfolio is most concentrated in Materials at 34% of assets, down from 34% a quarter earlier, followed by Technology and Energy.
- VanEck Associates's largest Q3 2022 buy was Valaris: 1,902,492 shares worth $93.1M.
- VanEck Associates added most to NVIDIA in Q3 2022, an estimated $174M increase.
- VanEck Associates's biggest Q3 2022 reduction was Kellanova, cutting an estimated $115M.
- VanEck Associates fully exited CoStar Group in Q3 2022, selling an estimated $86.7M.
- VanEck Associates's ten largest holdings make up 23% of its $33.6B portfolio in Q3 2022.
- VanEck Associates opened 70 new positions and closed 59 in Q3 2022.
- VanEck Associates's portfolio value fell 11% quarter-over-quarter to $33.6B.
Based on VanEck Associates's 13F filing for Q3 2022, filed 27 Oct 2022.